Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

S-44563 assessed in vivo in models of uveal melanoma

Dec. 13, 2011

ENGAGE-501 study evaluates entinostat in Hodgkin's lymphoma

Dec. 12, 2011

Acacia Pharma discloses phase IIa data on APD-209

Dec. 12, 2011

Amgen describes new ALK tyrosine kinase receptor inhibitors

Dec. 12, 2011

Janssen Biotech and Pharmacyclics enter agreement for anticancer drug

Dec. 12, 2011

New serine/threonine-protein kinase Chk1 inhibitor shows antitumor in vivo

Dec. 12, 2011

Genosco and Oscotec disclose promising therapeutics for acute myeloid leukemia

Dec. 12, 2011

Ono Pharmaceutical announces new launch in Japan

Dec. 9, 2011

Cyclacel Pharmaceuticals reports interim data from sapacitabine trials

Dec. 9, 2011

TetraLogic Pharmaceuticals begins new phase I/II TL-32711 trial

Dec. 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...